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Some epidemiologic studies have suggested that extremely low frequency magnetic fields 
might affect human health, and, in particular, that the incidence of certain types of cancer 
might increase among individuals living or working in environments exposed to such fields. 
This study is part of a broad study we conducted in humans. The study presented here was 
designed to look for possible effects of acute exposure to 50-Hz magnetic fields (10 μT) on 
the interleukin 1 beta (IL-1 ), interleukin 2 (IL-2), interleukin 6 (IL-6), interleukin-1 receptor 
antagonist (IL-1RA), and the interleukin-2 receptor (IL-2R) production. Thirty-two young 
men (20–30 years old) were divided into two groups (sham-exposed or control group, and 
exposed group) of 16 subjects each. All subjects participated in two 24-hour experiments to 
evaluate the effects of both continuous and intermittent (one hour “off” and one hour “on” 
with the field switched “on” and “off” every 15 seconds) exposure to linearly polarized 
magnetic fields. The subjects were exposed to the magnetic field from 2300 to 0800 while 
recumbent. Blood samples were collected during each session at 11:00, 17:00, 22:00, 01:00, 
04:00, 06:00 and 08:00. Results showed that exposure to 50-Hz magnetic fields (10 μT) 
significantly increases IL-6 when subjects were exposed to an intermittently magnetic field. 
However no effect has been observed on interleukin IL-1 , IL-2, IL-1RA, and IL-2R. 





It is well known that overhead transmission lines, transformers, and household appliances are 
major sources of electromagnetic field (EMF) exposure. For this reason a concern regarding 
the potential effect of extremely low frequency magnetic fields (ELF-EMF) on human health 
has been widely debated, the main concerns focusing on their carcinogenic potential and 
relationship with immune system functions.  This debate was stimulated by some 
epidemiological studies suggesting that exposure to 50–60Hz MFs may be associated with an 
increased incidence of various types of cancer (1-11). 
As the immune system is involved in the control of cancer development and other diseases, it 
is important to know whether or not immunological functions are affected by the exposure to 
ELF-MF. Several studies have examined various immune cell parameters but with conflicting 
findings. ELF-MF were reported to produce changes in the activity or the number of 
circulating natural killer (NK) cells (12-17).  However, no changes were observed in other 
studies (18- 22). 
Cytokines which are produced by a variety of cells were also investigated. Exposure to low 
frequency pulsed electromagnetic fields increased interleukin-1 and interleukin-6 production 
by human peripheral blood mononuclear cells (23). It has been shown that exposure to 50 Hz 
sinusoidal MFs decreased TNF-  production, while no effect was found on IFN-  production 
(24). Another study has also reported that 50 Hz electromagnetic fields decreased TNF-  and 
IFN-  production and increased IL-1  production (25). It is to note that all these studies on 
cytokine production have been conducted in vitro. Overall, the possible effects of ELF 
magnetic fields have been investigated in different types of cell cultures. On the other hand, 
there are only a limited number of human studies that are dedicated to the investigation of 
effects of ELF on the immune system. The study presented here was designed to look for 
 4 
possible effects of acute exposure to 50-Hz magnetic fields (10 μT) on the IL-1 , IL-2, IL-6, 
IL-1RA, IL-2R production in humans. 
 5 
 
Materials and Methods 
Human subjects 
Thirty-two healthy subjects volunteered for this study and provided written consent. All were 
men aged 20 to 30 years. They were selected after routine clinical and laboratory 
examinations. Selection criteria included: regular sleep habits, no medication, no chronic 
disease or disability, no recent acute illness, no smoking. Those selected were instructed to eat 
balanced meals and to abstain from consuming alcohol and coffee for 24 hours before and 
during each experimental session. They were synchronized with a diurnal activity from 08:00 
to 23:00 and nocturnal rest. 
 
Exposure facility 
The experimental unit consisted of three independent rooms and a shared bathroom. The 
exposed subjects slept in the first room (2 beds), and the sham-exposed in the second (2 beds). 
We did not inform subjects of their exposure status. The wooden beds were arranged parallel 
to each other in each room. Before setting up the exposure materials and beds, we used "Linda 
Wheel and EMDEX II dosimetry systems" to evaluate the noise of the background magnetic 
field. Its’ level was less than 40 nanotesla in both bedrooms. In the area immediately 
surrounding the experimental site, the flux density of the geomagnetic field was 
approximately 46 µT. Since a minimum distance of 6 m between exposed and sham-exposed 
beds is required to prevent the generated field from affecting the sham-exposed group, we 
spaced them 7 m apart. The devices for generation, calibration, and continuous monitoring of 




Magnetic field generation 
A linearly polarized magnetic field (10 µT) was generated by a system based on Helmholtz 
coils. Three rectangular coils (120 x 140 cm) spaced 80 cm apart were used for each bed. 
They were wrapped in wood and look like normal wooden stems attached to the bed and 
allowed subjects to feel comfortable towards the device.  The coils were positioned at the 
level of the head, groin and ankles. When energized the coils did not produce any vibration.  
The device was able to generate both continuous and intermittent exposure conditions. In the 
intermittent exposure, the device was turned “on” for one hour and “off” for the next hour. 
Whenever the device was turned “on”, the magnetic field was on a 15-second “on-off” cycle. 
Since “on-off” switching operations induce high frequency transient electric fields that can 
have a biological effect, the signal generator was monitored by computer and synchronized 
with passages at zero of the current wave to avoid any transient fields. The magnetic field was 
generated by a Tollner generator and amplified by a Kepco amplifier, all under a computer 
controled system developed by Electricité de France, Research and Development Department 
engineers. A "Positron" dosimeter system was attached to the subject's body at the height of 
the pelvis, to control the exposure quality and to verify that the device was working. The 10 
µT intensity was chosen as representative of the average level of exposure in occupational 
settings or near transmission lines for electrical workers after a dosimetry survey. 
 
Experimental procedure 
This experiment studied four subjects per day (2 exposed and 2 sham exposed), and each 
subject participated in three 24-hour sessions. They arrived at the laboratory at 09:30. 
Catheters were placed in antecubital vein for the 24-hour period, and the first blood sample 
was obtained at 11:00. They slept in darkness between 23:00 and 08:00 and spent their 
waking time in the laboratory (diurnal activity from 08:00 to 23:00 and nocturnal rest). Blood 
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samples (tubes without anticoagulant) were taken from 11:00 to 08:00 of the following day 
(11:00, 17:00, 22:00, 01:00, 04:00, 08:00). During the day, 15 minutes before each sampling, 
subjects were asked to lie down in semi recumbent position until sampling time. From 01:00 
to 08:00, the samples were obtained under dim light (less than 50 Lux) without waking the 
subjects, who slept with eye-mask from 23:00 to 08:00. Exposure to magnetic field lasted 
from 23:00 until 08:00.  
The first 24h session was performed before starting the experiment and leads subjects to be 
acclimated to the environment and devices.. We studied two groups: the first, sham-exposed, 
i.e., control (N = 12 - 16), and the other, exposed (N = 12-16). During the second session, two 
weeks after the first, a continuous 50-Hz magnetic field of 10 µT was applied. In the third 
session, a month after the second, the same subjects previously exposed to a continuous 
magnetic field were exposed to an intermittent 50-Hz magnetic field of 10 µT. The same 
subjects served as sham contols in both sessions. No one has reported an auditory or tactile 
cue that could be produced by the coils when energized. This protocol was approved by the 
local ethics committee. 
 
Cytokine assay 
IL-1RA (R&D System, Minneapolis, MN, USA), IL-2R (Genzyme Corporation, Cambridge, 
MA, USA), IL-1 , IL-2, IL-6 (Biosource, Europe S.A., Fleurus Belgium), were assayed by 
ELISA in duplicate using serum samples drawn during the two 24h study days. Sampling 
occurred at 11:00, 17:00, 22:00, 01:00, 04:00, 06:00, and 08:00. For inter- assay coefficients 




The data are expressed as means ± SEM. Data were analyzed with 2- way ANOVA repeated-
measures (GraphPad v5.02). The main effects of field, time factor and their interaction were 




Significant changes in the concentration of IL-6 were observed in the subjects exposed to 
intermittent MF. Bonferroni post-tests analysis showed an elevation in serum IL-6 was 
statistically significant at 06:00 and 08:00 with p < 0.01. However, exposure to continuous or 
intermittent magnetic fields of 10 µT did not affect or modify the cytokine production levels 
of IL-1 , IL-2, IL-1RA or IL-2R. No significant interaction between the field and the time of 
sampling was found (Table II). There was also no statistical significance of the main effects 




Epidemiological studies have shown an association between ELF exposure above 
approximately 0.3-0.4 μT and an increased risk of childhood leukemia (27, 28). However, 
despite several years of work, evidence from experimental studies to support a causal 
relationship between ELF exposure and leukemia is lacking and argues against causality. 
Thus ELF-MF exposure continues to generate a debate about its possible effects on health. In 
addition, there is no identified mechanism by which ELF-MF exposure in doses below 5 μT 
might affect the incidence of cancer or any other disease in the human population (29). As the 
immune system is involved in several types of cancers it is worthwhile to explore the effect of 
ELF-MF exposure on the immune system.  
 
Our present controlled study was conducted in humans who were exposed for one night to 
50Hz MF of 10 T from 23:00 to 08:00. Results showed that IL-6 production significantly 
increased in subjects exposed to intermittent but not with continuous exposure. Bonferroni 
post test showed that the significance is more observed in the last part of the night (06:00 and 
08:00). Since IL-6 shows a circadian rhythm with peak in the morning hours (30), the data 
presented may suggest a circadian stage depending stimulation of IL-6 production by the 
intermittent MF. The increase of IL-6 production during that time was approximately 4 to 5 
fold higher than control group. Even if non-significant, the upward trend for IL-6 was 
observed from 01:00 just after the onset of exposure time (23:00). IL-6 is a cytokine secreted 
predominantly by T-cells and macrophages with both pro- and anti-inflammatory effects.  IL-
6 stimulates the immune response to trauma and other tissue damage leading to inflammation 
(31).  Its role as an anti-inflammatory cytokine is mediated through its inhibitory effects on 
tumor necrosis factor alpha (TNFα) and IL-1 and activation of IL-1 RA and IL-10.  IL-6 is a 
regulator of body temperature and fever and mediator of the acute phase response (32). It 
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crosses the blood brain barrier and plays a role in neuroinflammation and some types of 
dementia (33).  IL-6 is relevant to many disease processes such as diabetes (34), 
atherosclerosis (35), depression (36), autoimmune diseases (37, 38, 39), and some forms of 
cancer (40, 41, 42, 43).  High levels of IL-6 and IL-6R have been reported in several chronic 
inflammatory and autoimmune diseases as well as in cancer (44, 45, 46). However, the 
cytokine production levels of IL-1 , IL-2, IL-1RA and IL-2R were not affected by the MF 
exposure neither in the continuous mode nor in the intermitten mode.  
 
To date, and to our knowledge, information regarding the effects of extremely low frequency 
MF on human cytokines is scarce. Most studies were carried out in in vitro models. These 
studies on the peripheral blood mononuclear cells cultures (PBMC) have shown conflicting 
results. Some authors reported an increase of cytokine production such as IFN-  and IL-4, IL-
1, and IL-6 (23, 25, 47) after exposure to ELF-MF or a decrease in TNF-  and IFN-  
production (25) while others did not find any effect on IL-1 , IL-8, IFN- , TNF- , IL-10,  IL-
6 and IL-2 production (24, 48, 47, 22, 49). This inconsistency in the results might be due to 
the difference in the type of the magnetic field and/or the intensities used. 
 
In our study, the effect observed on IL-6 was obtained with intermittent and not with 
continuous exposure. It is to note that a similar effect in vitro (an increase of IL-6) in the 
literature has been reported with pulsed magnetic field (23), while no effect was found with 
static or continuous alternating magnetic field (47, 49). It is likely that the type of MF applied 
may be of importance and could have a different impact on the production of IL-6. Further 
confirmation of these findings in human subjects are desirable. 
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In animal studies, only a few studies have investigated cytokine production in immune cells 
after exposure to ELF EMFs. Some authors have reported that exposure of sheep to EMF had 
no effect on the activity of IL-1 or IL-2 (50). A reduction in IL-1 activity was observed in 
their previous studies (51). The authors concluded that the difference observed in the results 
might be attributed to magnetic field strength and/or the age of the animals used which could 
be important variables in determining whether EMF exposure will affect IL-1 activity. 
Another study has reported that exposure to 1 mT ELF-MF increased IL-1  at transcriptional 
and translational level in rat cortical neurons (52). IL-1  release was also reported to increase 
in macrophages after 24 h exposure to 1 mT of 50Hz MF (53)  
 
Conclusions: 
The results obtained for IL-6 in the present study should be interpreted with caution and  
require further studies and confirmation to ascertain if the effect observed is due to MF 
exposure and reproducible. It is also important to stress the potential clinical significance of 
this increase of IL-6 concentration particularly since its receptor (IL-6R) had been found to be 
increased under exposure to MF (54). 
Overall, the lack of effect observed in the present study on IL-1beta, IL-2, IL-1RA and IL-2R 
supports our previous findings in which acute exposure (9 hours) to 50-Hz magnetic fields (10 
T) did not affect the immunologic and hematologic systems (19), melatonin secretion (26), 
hormones of the hypothalamo-pituitary-thyroid and adrenal axis (55), and a large number of 
clinical chemistry variables (56) including biogenic amines (57). Even our chronic study on 
workers exposed daily to magnetic fields for a period of 1–20 yr in their workplace and at 
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Table I. Coefficients of variation for low and high controls for the measured variables  
Variables Units 
Control I (Low values) 
 
Control II (High values) 
Range Mean CV 
 
Range Mean CV 
Interleukin-1 Beta pg/ml 79 - 129 105.3 9.7% 
 
380 - 580 514.5 9.8% 
Interleukin-1 RA   
[Receptor Antagonist] 
pg/ml 66.7 - 73.7 72.5 19.0% 
 
534.8 - 591.2 547.1 5.4% 
Interleukin-2 U/ml 3.9 - 6.5 5.0 17.6% 
 
10.0 - 15.0 14.2 11.6% 
Interleukin-2R 
[Receptor] 
pg/ml 1002 - 1502 1247.7 9.4% 
 
3187 - 4781 3784.8 17.5% 
Interleukin-6 pg/ml 91 - 137 120.9 8.2% 
 




Table II: Repeated-measures 2-way ANOVA: comparison between exposed and sham 
exposed by examining the main effects of the field (continuous or intermittent), the 
time factor and their interaction. 
 
 
Variables/factors   Continuous exposure  Intermittent exposure 
      P    P 
 
IL-6 
Field      0.2878    0.0186 
Time      0.1156    < 0.0001  
Field X Time interaction    0.5635    0.0032 
 
IL-1RA 
Field       0.5198    0.3455 
Time      0.0012    0.0042 




Field      0.5556    0.6382 
Time      0.7566    0.6379  
Field X Time interaction    0.2267    0.4402  
 
IL-2 
Field      0.7220    0.3851 
Time      0.0962    0.5906  
Field X Time interaction    0.5663    0.1425 
 
IL-2R 
Field      0.0768    0.1441 
Time      0.0584    < 0.0001  
Field X Time interaction    0.9721    0.9587 
 
 
 
